PRIMIS has developed stand-alone system searches to help practices identify patients who may be at increased risk of hospitalisation. These patients are not necessarily at an increased risk of contracting Covid-19 but, by keeping them out of hospital, it will help to reduce the current pressure on secondary care services. Equally, as these searches identify patients who are already presenting with long term conditions, these patients may experience complications if they do contract Covid-19. These searches can be downloaded and imported into your GP clinical system FREE OF CHARGE.
If you are looking for information regarding the Coronavirus (Covid-19) shielded patients list, please refer to the NHS Digital website.
The patients identified in these searches may be sub-optimally treated or poorly controlled and would benefit from a structured medication review.
*Factors suggesting greater likelihood of a beneficial response to ICS include those with a history of asthma, blood eosinophil counts based upon exacerbations. Ref: GOLD COPD strategy and NICE NG115
Click to fill out a brief form to request these searches
Medication safety targeted searches have been removed. The National PINCER inidcator searches can help practices to identify patients who are potentially at risk of harm which can help to reduce demand on secondary care (in terms of emergency admissions) if that risk is mitigated.
The current national PINCER indicators help identify patients at risk of GI bleed, patients on high risk drugs with absent essential monitoring and other important and preventable causes of patient safety incidents.
Find out more about PINCER
Please contact your local AHSN Medicines Optimisation Team to enquire about participating in the rollout of PINCER. (If you do not know your local AHSN, email PRIMIS to be signposted to your Medicines Optimisation Team contacts).
PRIMIS offers a range of clinical quality improvement tools to help practices support their patients with long term condition management. These tools are made available to practices free of charge thanks to national sponsorship. Many of the code groups and associated query logic for the above targeted searches reside within the more comprehensive GRASP-DM and GRASP-COPD tools, which were developed with funding from Boehringer Ingelheim.*
* Boehringer Ingelheim have undertaken a medico legal review of the GRASP tools but PRIMIS retains editorial control and IP rights.
Email us email@example.com
Helpdesk 0115 846 6424
General office and non-helpdesk enquiries 0115 846 6420
Please see Contacting us for further details
Browser does not support script.